Effects of cinnamon on blood pressure and metabolic profile: a double-blind, randomized, placebo-controlled study in patients with stage 1 hypertension - Evidence review

In a double-blind randomized placebo-controlled trial in stage 1 hypertension, 1,500 mg/day of cinnamon lowered systolic blood pressure and improved HDL/LDL.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-11
DOI
https://doi.org/10.5281/zenodo.24140438
Primary Topic
Blood Pressure and Hypertension Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Effects of cinnamon on blood pressure and metabolic profile: a double-blind, randomized, placebo-controlled study in patients with stage 1 hypertension - Evidence review

Armando Colonnese
Zenodo (CERN European Organization for Nuclear Research)
Blood Pressure and Hypertension Studies
article

Effects of cinnamon on blood pressure and metabolic profile: a double-blind, randomized, placebo-controlled study in patients with stage 1 hypertension - Evidence review

Armando Colonnese
article en

Abstract

In a double-blind randomized placebo-controlled trial in stage 1 hypertension, 1,500 mg/day of cinnamon lowered systolic blood pressure and improved HDL/LDL.

Zenodo (CERN European Organization for Nuclear Research)
Blood Pressure and Hypertension Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
Effects of cinnamon on blood pressure and metabolic profile: a double-blind, randomized, placebo-controlled study in patients with stage 1 hypertension - Evidence review — Armando Colonnese · Zenodo (CERN European Organization for Nuclear Research) (2026) | TGRS Research Map | TGRS